| Epidemiology, Prevalence, Incidence in Behçet’s Disease | MELİKE BALIKOĞLU YILMAZ,Yusuf Ziya GÜVEN | 321–323 |
| Etiopatogenesis of Behçet’s Disease | Abdulbaki MUDUN | 324–328 |
| Clinical Findings, Diagnosis and Classification of Behçet’s Disease | Suzan GÜVEN YILMAZ,Berna YÜCE,Halil ATEŞ | 329–333 |
| Fluorescein Angiography, Wide Field Angiography and Indocyanine Green Angiography in Behcet Uveitis | Nurettin AKYOL,Dilek UZLU | 334–337 |
| Fundus Autofluorescence and Optical Coherence Tomography Findings in Behçet’s Disease | Sirel GÜR GÜNGÖR,Almila SARIGÜL SEZENÖZ | 338–342 |
| Use of Oral Steroids and Immunosuppressant / Immunomodulators in the Treatment of Behcet’s Disease-Related Uveitis | MUHAMMED BATUR,Muhammet Derda ÖZER,SEREK TEKİN | 343–347 |
| Periocular and Intravitreal Steroid Use in Treatment of Behcet’s Disease Related Uveitis | ALPER YAZICI,Esin SÖĞÜTLÜ SARI | 348–351 |
| Interferons in the Treatment of Behçet Uveitis | HİLAL ESER ÖZTÜRK,YÜKSEL SÜLLÜ | 352–357 |
| Biologics in Treatment of Behçet Uveitis | HİLAL ESER ÖZTÜRK,İlknur Tuğal TUTKUN | 358–365 |
| Unresponsiveness to Treatment, Pharmaceutical Alterations and Combined Treatments in Behçet’s Disease | Merih SOYLU,Müge ÇOBAN KARATAŞ | 366–370 |
| Newly Developed Therapies for Uveitis Associated With Behçet’s Disease | GAMZE UÇAN GÜNDÜZ,Zeynep GÜLLÜLÜ,ÖZGÜR YALÇINBAYIR | 371–375 |
| Use of Anti-VEGF Agents and Lasers in Behçet’s Disease | Sibel KADAYIFÇILAR | 376–379 |
| Intraocular Surgery in Behçet’s Disease | ZİYA AYHAN,Ali Osman SAATÇİ | 380–383 |
| Ocular Involvement, Prognosis and Complications in Behçet’s Disease | CEM EVEREKLİOĞLU,Çağatay KARACA | 384–387 |
| Clinical Features, Diagnosis And Treatment Of Pediatrıc Behçet and Late Onset Behçet Disease |